Pseudoxanthoma elasticum

Czech version

Authors: A. Kováčiková Curková; E. Rasochová
Authors‘ workplace: Dermatovenerologická klinika LF UK a Univerzitnej Nemocnice Bratislava – emocnica Staré Mesto, prednostka prof. MUDr. Mária Šimaljaková, Ph. D.
Published in: Čes-slov Derm, 85, 2010, No. 4, p. 219-223
Category: Case Reports

Overview

Pseudoxanthoma elasticum is mostly an autosomal recessive genetic disorder caused by mutations in the ABCC6 gene. It is characterised by progressive mineralization and fragmentation of elastic fibers in the skin, retina and blood vessels. The cutaneous features bring the patient to medical attention, but the morbidity is related to the degree of extracutaneous involvement. The disease is progressive with phenotypic variability and no definite genotype-phenotype correlation. It is an incurable disease, the treatment being only supportive – focused on the prevention and early detection of adverse ocular and cardiovascular events. We would like to highlight the role of dermatologists in detecting this rare disorder and advising an appropriate screening for complications.

Key words:
pseudoxanthoma elasticum – elastic fibers mineralization – cutaneous and extracutaneous manifestations – differential diagnosis – regular follow-up

Sources

1. BRAUN-FALCO, O., PLEWIG, G., WOLFF, HH. Dermatológia a Venerológia. Osveta Martin, 2001, s. 651-653.

2. BYUN, JY., DO, MO., KIM, SH., CHOI, HY., MYUNG, KB., CHOI, YW. Pseudoxanthoma elasticum-like papillary dermal elastolysis developed in early middle age. J Dermatol, 2007, 34, p. 709-711.

3. DIEKMANN, U., ZARBOCK, R., HENDIG, D., SZLISKA, C., KLEESIEK, K., GOETTING, C. Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients. J Mol Med, 2009, 87(10), p. 965-970.

4. GRANSSAUGE, M., WILHELM, H., BAERTZ-SCHMIDT, KU., AISENBREY, S. Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angioid streaks in pseudoxanthoma elasticum. Graefes Arch Clin Exp Ophthalmol, 2009, 247(12), p. 1707-1710.

5. LACINA, L., KOJANOVÁ, M., ŠLAJSOVÁ, M., ŠTORK, J. Klinický případ: Žlutavé splývající papuly na šíji. Pseudoxanthoma elasticum. Čes.-slov. Derm, 2006, 81, 2, s. 99-101.

6. LaRUSSO, J., LI, Q., JIANG,Q., UITTO, J. Elevated dietary magnesium prevents connective tissue mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6(-/-)). J Invest Dermatol, 2009, 129(6), p. 1388-1394.

7. LEE, HS., SONG, HJ., HONG, WK., SHIN, JH., CHOI, GS.: Pseudoxanthoma-like papillary dermal elastolysis with solar elastosis. JEADV, 2008, 22, p. 368-369.

8. LEWIS, BK., CHERN, PL., STONE, MS. Penicillamine –induced elastosis of the mucosal lip. J Am Acad Dermatol, 2009, 60(4), p. 700-703.

9. PLOMP, AS., BERGEN, AA., FLORIJN, RJ., TERRY, SF., TOONSTRA, J., VAN DIJK, MR., DE JONG, PT. Pseudoxanthoma elasticum: Wide phenotypic variation in homozygotes and no signs in heterozygotes for the c.3775delT mutation in ABCC6. Genet Med, 2009, 11(12), p. 852-858.

10. TAKATA, T., IKEDA, M., KODAMA, H., KITAGAWA, N. Treatment of Pseudoxanthoma elasticum with tocopherol acetate and ascorbic acid. Pediatric Dermatology, 2007, 24(4), p. 424-425.

11. YU, S., MING, A., WEGMAN, A. Pseudoxanthoma elasticum-like lesions in association with thalassaemia major. Australas J Dermatol, 2009, 50(3), p. 186-189.

Labels

Dermatology & STDs Paediatric dermatology & STDs

Current Developments and New Treatment Options in the Therapy of Melanoma

The Follow-up of Patients with Severe Acne Vulgaris Treated with Systemic Isotretinoin

Nystatin – Newly Available Drug for Extemporaneous Preparation

Commentary to the Guidelines of The European Dermatology Forum on the Systemic Treatment of Psoriasis Vulgaris

Article was published in

Czech-Slovak Dermatology

2010 Issue 4